mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.08 |